Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
295.75
+3.68 (1.26%)
At close: Mar 17, 2026, 4:00 PM EDT
297.97
+2.22 (0.75%)
After-hours: Mar 17, 2026, 7:50 PM EDT

Elevance Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
49,31150,08749,42148,76544,98944,71943,22342,27342,45442,48043,37741,89839,66739,62538,48237,88636,01835,54833,27932,098
Revenue Growth (YoY)
9.61%12.00%14.34%15.36%5.97%5.27%-0.36%0.90%7.03%7.21%12.72%10.59%10.13%11.47%15.63%18.03%14.22%15.98%14.06%9.00%
Cost of Revenue
43,58743,52041,99940,29539,51238,04235,39234,37136,17135,25435,93134,26733,89232,84131,86431,11430,53429,54327,37726,012
Gross Profit
5,7246,5677,4228,4705,4776,6777,8317,9026,2837,2267,4467,6315,7756,7846,6186,7725,4846,0055,9026,086
Selling, General & Admin
5,4155,2724,9975,3004,8045,2695,0664,8864,9995,4704,8184,8004,5674,5144,2724,3454,2223,9463,8213,925
Depreciation & Amortization Expenses
1641621471551801221621162172122212352472251661291351369080
Other Operating Expenses
5,4155,2724,9975,3004,8045,2695,0664,8864,9995,4704,8184,8004,567-4,2724,345----
Total Operating Expenses
10,99410,70610,14110,7559,78810,66010,2949,88810,21511,1529,8579,8359,3814,7398,7108,8194,3574,0823,9114,005
Operating Income
-5,270-4,139-2,719-2,285-4,311-3,983-2,463-1,986-3,932-3,926-2,411-2,204-3,6062,045-2,092-2,0471,1271,9231,9912,081
Interest Income
493625486590527551508465529493416387373371381360352335400291
Interest Expense
-366-351-341-344-340-300-280-265-259-259-261-251-229-213-208-201-200-201-205-192
Other Non-Operating Income (Expense)
-57-1-131-464-74-164155-161-336-124-121-113-111-57-231-151195-61167-4
Total Non-Operating Income (Expense)
7027314-2181138738339-66110342333101-5883477336295
Pretax Income
2151,4062,2922,7976061,3732,9862,9391,0011,6542,4412,6199852,1462,1222,3061,4701,9962,3532,176
Provision for Income Taxes
-331219548613193365685690170354585615155533488527291494552509
Net Income
5471,1891,7432,1834181,0162,3002,2468561,2891,8531,9898181,6181,6371,7891,1911,5091,7931,665
Minority Interest in Earnings
-1-211-5-813-251131512-5-3-10-24-782
Net Income to Common
5471,1891,7432,1834181,0162,3002,2468561,2891,8531,9898181,6181,6371,7891,1911,5091,7931,665
Net Income Growth
30.86%17.03%-24.22%-2.80%-51.17%-21.18%24.12%12.92%4.64%-20.33%13.20%11.18%-31.32%7.22%-8.70%7.45%116.15%579.73%-21.22%9.32%
Shares Outstanding (Basic)
222223225226231232232233236235237238241240241241246243245245
Shares Outstanding (Diluted)
222224226227231233233234236237238240241242243244246246247248
Shares Change (YoY)
-4.02%-4.03%-3.26%-2.99%-1.99%-1.44%-1.85%-2.30%-2.24%-2.35%-2.30%-1.92%-1.75%-1.54%-1.62%-1.53%-2.23%-3.23%-3.13%-3.20%
EPS (Basic)
2.475.327.749.641.814.389.919.653.635.487.838.373.596.696.807.414.636.207.336.80
EPS (Diluted)
2.475.327.729.611.814.369.859.593.635.457.798.303.596.626.737.324.636.137.256.71
EPS Growth
36.46%22.02%-21.62%0.21%-50.14%-20.00%26.44%15.54%1.11%-17.67%15.75%13.39%-22.46%7.99%-7.17%9.09%111.42%604.60%-18.63%12.96%
Free Cash Flow
-2097751,7878213842,3451241,699-3,2972,2941,6006,168-1,8164,6192,1572,2871,3322,2461,3982,301
Free Cash Flow Growth
--66.95%1341.13%-51.68%-2.22%-92.25%-72.45%--50.34%-25.82%169.70%-105.65%54.29%-0.61%-62.32%--73.51%-0.43%
Free Cash Flow Per Share
-0.943.467.913.611.6610.060.537.25-13.989.706.7325.73-7.5319.078.869.365.439.135.659.27
Dividends Per Share
1.7101.7101.7101.7101.6301.6301.6301.6301.4801.4801.4801.4801.2801.2801.2801.2801.1301.1301.1301.130
Dividend Growth
4.91%4.91%4.91%4.91%10.13%10.13%10.13%10.13%15.63%15.63%15.63%15.63%13.27%13.27%13.27%13.27%18.95%18.95%18.95%18.95%
Gross Margin
11.61%13.11%15.02%17.37%12.17%14.93%18.12%18.69%14.80%17.01%17.17%18.21%14.56%17.12%17.20%17.87%15.23%16.89%17.73%18.96%
Operating Margin
-10.69%-8.26%-5.50%-4.69%-9.58%-8.91%-5.70%-4.70%-9.26%-9.24%-5.56%-5.26%-9.09%5.16%-5.44%-5.40%3.13%5.41%5.98%6.48%
Profit Margin
1.11%2.37%3.53%4.48%0.92%2.25%5.32%5.32%1.96%3.06%4.28%4.78%2.09%4.07%4.25%4.70%3.27%4.23%5.41%5.19%
FCF Margin
-0.42%1.55%3.62%1.68%0.85%5.24%0.29%4.02%-7.77%5.40%3.69%14.72%-4.58%11.66%5.61%6.04%3.70%6.32%4.20%7.17%
EBITDA
-4,665-3,752-2,339-1,912-3,913-3,654-2,128-1,655-3,508-3,500-1,978-1,742-3,1332,496-1,699-1,6891,4872,2742,3002,363
EBITDA Margin
-9.46%-7.49%-4.73%-3.92%-8.70%-8.17%-4.92%-3.92%-8.26%-8.24%-4.56%-4.16%-7.90%6.30%-4.42%-4.46%4.13%6.40%6.91%7.36%
EBIT
-5,270-4,139-2,719-2,285-4,311-3,983-2,463-1,986-3,932-3,926-2,411-2,204-3,6062,045-2,092-2,0471,1271,9231,9912,081
EBIT Margin
-10.69%-8.26%-5.50%-4.69%-9.58%-8.91%-5.70%-4.70%-9.26%-9.24%-5.56%-5.26%-9.09%5.16%-5.44%-5.40%3.13%5.41%5.98%6.48%
Effective Tax Rate
-153.95%15.58%23.91%21.92%31.85%26.58%22.94%23.48%16.98%21.40%23.97%23.48%15.74%24.84%23.00%22.85%19.80%24.75%23.46%23.39%
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q